Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Issuers ranked
1,211
Showing 50 of 1,211
Quality filters
10+ trades
≥3 insiders, 50% price coverage
Window
5y trailing
Trade date filter
| # | Ticker | Issuer | Trades | Insiders | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|---|
| 1 | MNPR | Monopar Therapeutics | 11/12 | 3 | 100% | +745.4% | +734.0% | +944.8% | +348.2% |
| 2 | TDUP | Thredup Inc. | 29/31 | 7 | 76% | +616.3% | +452.4% | +1411.3% | -68.8% |
| 3 | NUTX | Nutex Health, Inc. | 26/31 | 11 | 35% | +418.1% | -46.7% | +2414.8% | -91.5% |
| 4 | SMMT | Summit Therapeutics Inc. | 18/25 | 5 | 100% | +395.5% | +348.3% | +1105.4% | +76.2% |
| 5 | RLMD | Relmada Therapeutics, Inc. | 26/35 | 6 | 31% | +334.1% | -44.1% | +1281.1% | -91.0% |
| 6 | UAMY | United States Antimony Corp | 14/15 | 5 | 50% | +333.7% | +158.6% | +1142.1% | -48.9% |
| 7 | YELLQ | Yellow Corp | 38 | 16 | 66% | +329.0% | +212.5% | +858.8% | -67.4% |
| 8 | SLNO | Soleno Therapeutics Inc | 89 | 10 | 91% | +316.9% | +82.0% | +871.3% | -36.0% |
| 9 | TOI | Oncology Institute, Inc. | 21/32 | 10 | 90% | +316.0% | +156.2% | +1797.4% | -82.2% |
| 10 | SEZL | Sezzle Inc. | 20/40 | 3 | 95% | +2603.7% | +3123.8% | +4449.0% | -19.4% |
| 11 | VERA | Vera Therapeutics, Inc. | 49/54 | 15 | 71% | +297.8% | +445.9% | +578.7% | -65.0% |
| 12 | LUMN | Lumen Technologies, Inc. | 10/18 | 5 | 100% | +291.4% | +197.8% | +593.8% | +0.2% |
| 13 | PIRS | Pieris Pharmaceuticals, Inc. | 10/15 | 7 | 100% | +288.6% | +173.5% | +716.3% | +137.2% |
| 14 | HYLN | Hyliion Holdings Corp. | 14/15 | 10 | 86% | +281.0% | +319.5% | +450.0% | -45.7% |
| 15 | KINS | Kingstone Companies, Inc. | 24/28 | 5 | 96% | +240.1% | +180.9% | +582.7% | -4.0% |
| 16 | ASPI | Asp Isotopes Inc. | 25/26 | 7 | 100% | +237.0% | +126.9% | +1265.6% | +51.5% |
| 17 | MYO | Myomo, Inc. | 19/34 | 9 | 58% | +233.4% | +61.1% | +831.8% | -86.3% |
| 18 | SEPN | Septerna, Inc. | 52 | 14 | 100% | +230.0% | +363.2% | +443.3% | +7.6% |
| 19 | HOVR | New Horizon Aircraft Ltd. | 52/56 | 4 | 92% | +219.4% | +167.1% | +763.5% | -7.8% |
| 20 | HROW | Harrow, Inc. | 19/23 | 6 | 100% | +188.2% | +160.9% | +429.1% | +98.1% |
| 21 | AAOI | Applied Optoelectronics, Inc. | 12/23 | 4 | 67% | +186.9% | +55.6% | +999.6% | -36.6% |
| 22 | ZIVO | Zivo Bioscience, Inc. | 22/42 | 7 | 41% | +184.4% | -9.1% | +1640.8% | -67.2% |
| 23 | NANX | Nanophase Technologies Corp | 65/95 | 4 | 100% | +184.2% | +163.9% | +454.9% | +111.4% |
| 24 | CATC | Cambridge Bancorp | 11 | 5 | 100% | +181.1% | +40.2% | +1546.2% | +40.2% |
| 25 | IAUX | I-80 Gold Corp. | 13/22 | 10 | 100% | +177.8% | +164.9% | +193.0% | +164.9% |
| 26 | CLOV | Clover Health Investments, Corp. /De | 12/16 | 4 | 83% | +169.5% | +123.8% | +404.8% | -69.9% |
| 27 | LBSR | Liberty Star Uranium & Metals Corp. | 21 | 5 | 57% | +169.5% | +176.6% | +585.7% | -79.0% |
| 28 | UEC | Uranium Energy Corp | 13 | 3 | 100% | +169.1% | +177.5% | +177.5% | +150.2% |
| 29 | SRRK | Scholar Rock Holding Corp | 37/46 | 12 | 100% | +166.6% | +228.9% | +245.5% | +65.9% |
| 30 | NNBR | Nn Inc | 186 | 16 | 72% | +157.7% | +234.0% | +343.9% | -62.5% |
| 31 | LMB | Limbach Holdings, Inc. | 34/35 | 11 | 97% | +156.7% | +137.4% | +278.1% | -20.5% |
| 32 | PHAT | Phathom Pharmaceuticals, Inc. | 23 | 6 | 96% | +155.6% | +121.7% | +427.9% | -21.9% |
| 33 | LFMD | Lifemd, Inc. | 21 | 8 | 86% | +153.2% | +174.1% | +277.1% | -59.2% |
| 34 | BKTI | Bk Technologies Corp | 25 | 9 | 76% | +153.0% | +231.3% | +291.8% | -19.6% |
| 35 | PPTA | Perpetua Resources Corp. | 16/17 | 8 | 75% | +145.3% | +144.8% | +318.2% | -12.8% |
| 36 | GDRZF | Gold Reserve Ltd | 80 | 5 | 100% | +140.8% | +136.6% | +204.7% | +93.8% |
| 37 | PRLD | Prelude Therapeutics Inc | 25/35 | 9 | 64% | +138.7% | +111.9% | +384.2% | -25.2% |
| 38 | TKNO | Alpha Teknova, Inc. | 33/35 | 13 | 70% | +137.6% | +179.9% | +266.2% | -78.6% |
| 39 | TGEN | Tecogen Inc. | 100/108 | 8 | 51% | +137.5% | +2.1% | +1019.3% | -39.1% |
| 40 | RDW | Redwire Corp | 11/19 | 6 | 45% | +137.2% | -7.7% | +445.3% | -34.8% |
| 41 | VSCO | Victoria'S Secret & Co. | 10/13 | 4 | 100% | +133.2% | +145.2% | +224.5% | +19.0% |
| 42 | GTHP | Guided Therapeutics Inc | 15/18 | 4 | 73% | +132.0% | +200.0% | +239.8% | -73.7% |
| 43 | PRPO | Precipio, Inc. | 18/25 | 3 | 72% | +127.9% | +146.1% | +356.8% | -60.6% |
| 44 | APGE | Apogee Therapeutics, Inc. | 21 | 8 | 100% | +127.0% | +132.6% | +132.6% | +73.9% |
| 45 | ZVIA | Zevia Pbc | 10 | 7 | 80% | +126.9% | +143.9% | +205.3% | -22.3% |
| 46 | TERN | Terns Pharmaceuticals, Inc. | 18/24 | 7 | 44% | +124.8% | -24.0% | +513.3% | -45.4% |
| 47 | LC | Lendingclub Corp | 18 | 13 | 89% | +124.6% | +180.3% | +180.3% | -46.8% |
| 48 | HRTG | Heritage Insurance Holdings, Inc. | 32/36 | 10 | 100% | +123.2% | +107.4% | +214.4% | +44.8% |
| 49 | SOI | Solaris Oilfield Infrastructure, Inc. | 18/26 | 6 | 100% | +120.9% | +100.2% | +237.9% | +44.4% |
| 50 | BYRN | Byrna Technologies Inc. | 16/18 | 8 | 63% | +118.8% | +44.9% | +341.5% | -70.5% |
Showing 1-50 of 1,211